Clinical trial
Combination Osteogenic Therapy in Established Osteoporosis
NCT00018447 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00018447 |
|---|---|
| Title | Combination Osteogenic Therapy in Established Osteoporosis |
| Official title | Combination Osteogenic Therapy in Established Osteoporosis |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoporosis, Post-Menopausal |
| Intervention type | Drug |
| Interventions | PTH 1-34, MFPSR-fluoride |
| Start date | Nov 1, 1998 |
| Completion | Oct 1, 2003 |
| First posted | Jul 5, 2001 |
| Last update posted | Jan 21, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: